AUTHOR=Mohan M. E. , Mohan Mohind C. , Prabhakaran Prathibha , Syam Das S. , Krishnakumar I. M. , Baby Chakrapani P. S. 

TITLE=Exploring the short-term influence of a proprietary oil extract of black cumin (Nigella sativa) on non-restorative sleep: a randomized, double-blinded, placebo-controlled actigraphy study

JOURNAL=Frontiers in Nutrition

VOLUME=10

YEAR=2024

URL=https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1200118

DOI=10.3389/fnut.2023.1200118

ISSN=2296-861X

ABSTRACT=<sec id="sec1"><title>Background</title><p><italic>Nigella sativa</italic> (black cumin, or black seed) is popularly known as the seed of blessings in the Arab system of medicine. Though not widely recommended for sleep, a unique proprietary black cumin extract (BlaQmax®/ThymoDream™; BCO-5) has been shown to be helpful in the management of stress and sleep issues.</p></sec><sec id="sec2"><title>Methods</title><p>This randomized, double-blind, placebo-controlled trial aimed to investigate the efficacy of BCO-5 on the sleep quality of volunteers characterized with a self-reported non-restorative sleep disorder. Healthy male and female participants (<italic>n</italic> = 70), aged 18-65 years (BMI 22-28 Kg/m<sup>2</sup>) were randomized to either placebo or BCO-5 (<italic>n</italic> = 35/group). Both interventions were supplemented at 200 mg/day for seven days. Actigraphy and a validated restorative sleep questionnaire (RSQ-W) were used to monitor the influence of BCO-5 on sleep.</p></sec><sec id="sec3"><title>Results</title><p>Compared to placebo, BCO-5 significantly improved sleep quality, as evidenced by both intra-group and inter-group analyses of the actigraphy data. The relative improvements observed were sleep efficiency (7.8%, <italic>p</italic> &lt; 0.001), total sleep time (19.1%, <italic>p</italic> &lt; 0.001), sleep onset latency (35.4%; <italic>p</italic> &lt; 0.001), and wake-after-sleep-onset (22.5%; <italic>p</italic> &lt; 0.001) compared with placebo. BCO-5 also improved sleep by 75.3% compared to baseline (<italic>p</italic> &lt; 0.001) and by 68.9% compared to placebo (<italic>p</italic> &lt; 0.001), when monitored by RSQ-W. BCO-5 was well-tolerated with no reports of side effects or toxicity.</p></sec><sec id="sec4"><title>Conclusion</title><p>BCO-5 significantly improved non-restorative sleep in seven days, indicating its potential role as a natural sleep aid.</p></sec>